
GC72797
Moxilubant
Also known as 4-[5-(4-carbamimidoylphenoxy)pentoxy]-3-methoxy-N,N-di(propan-2-yl)benzamide
Moxilubant (CGS-25019C;LTB-019) is an orally active BLT1 antagonist which inhibits LTB4 signaling with a potency of 2-4 nM
ChemicalCAS146978-48-5MW455.59FormulaC26H37N3O4
- CAS number
- 146978-48-5
- Molecular weight
- 455.59
- Formula
- C26H37N3O4
- Solubility
- DMSO : 62·5 mg/mL (137·18 mM; Need ultrasonic)
- InChIKey
- VAYJLOGCWOXMAS-UHFFFAOYSA-N
- Catalogue number
- GC72797
- Brand
- GLPBIO
Computed properties PubChem CID 9955657 · XLogP 4.6 · TPSA 97.9 Ų · H-bond donors 2
- XLogP
- 4.6
- TPSA
- 97.9 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 13
- Heavy atoms
- 33
SMILES CC(C)N(C(C)C)C(=O)C1=CC(=C(C=C1)OCCCCCOC2=CC=C(C=C2)C(=N)N)OC
Computed descriptors from PubChem (CID 9955657), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il